Home > What we do > Medicine & Healthcare > hMedicine > hMedicine Archive

hMedicine Archive

Showing 241 to 260 of 352      First | Prev | 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 | Next | Last
Kenyan Doctor Achieves His Dream at Hadassah Medical Center
A Kenyan physician, the son of subsistence farmers from one of the poorest districts near the border of Tanzania, achieved his dream of becoming an interventional radiologist through a fellowship at the Hadassah University Medical Center. Date: 7/12/2012


Muslim Reporter Spotlights Egalitarian Atmosphere at HMO
When Prof. Chaim Lotan, Director of the Hadassah University Medical Center's Heart Institute, met Souad Mekhennet, a reporter for The New York Times, who was in Jerusalem to cover an international event, he invited her to visit Hadassah. Date: 7/12/2012


New Trial Drug Cures Patient with ALS
A new treatment for amyotrophic lateral sclerosis (ALS) based on stem cell technology and now in clinical trials at Hadassah, appears to have cured an Orthodox Rabbi in Israel who was diagnosed with the disease two years ago. Date: 7/3/2012


Hadassah Initiates Endoscopic Treatment for Babies' Blocked Esophagus, Replacing Risky Surgery
For the first time in Israel, doctors at the Hadassah University Medical Center are employing endoscopic intervention to correct fistula (abnormal connections of the esophagus and trachea) in babies, avoiding the risky conventional surgical option. Date: 6/26/2012


Hadassah Nurse Develops New Initiative to Ease Examination of Child Victims of Sexual Abuse
Thanks to the ingenuity of a Hadassah University Medical Center nurse, child victims of sexual abuse are being put at ease with therapeutic dolls, so they are more apt to allow clinical examination, which can provide officials with evidence against their attackers. Date: 6/26/2012


Hadassah Researchers Develop Human Embryonic Stem Cell Lines Suitable for Humans
Researchers at the Hadassah University Medical Center in Jerusalem have produced, for the first time, under Good Manufacturing Practices (GMP) conditions, lines of human embryonic stem cells (hESCs) for transplantation that are free of animal components. Date: 6/26/2012


Cord Blood Stem Cells Improve Life for Baby with Brain Injury
With cord blood stem cells preserved at the Hadassah University Medical Center, an Israeli baby with a brain injury received a transplant at Duke University Medical Center, North Carolina, and was able to walk with a walker and wave her hand- which had previously been paralyzed.  Date: 6/15/2012


Gastroenterology Problem on a Mediterranean Cruise Lands Nebraskan at Hadassah
While on a cruise on the Mediterranean Sea, Patrick Griffin from Nebraska became ill with a gastroenterology problem. When it was ultimately determined he needed surgery, Mr. Griffin’s sister connected him to an air ambulance company in Tel Aviv which, in turn, referred him to the Hadassah University Medical Center’s Prof. David Linton, Director of Intensive Care Medicine, who is also a pilot. Date: 6/15/2012


Hadassah Perseverance Ensures That Patient Gets a New Kidney
The persistence of the organ transplant coordinator at the Hadassah University Medical Center in reaching a patient who had been waiting for five years for a kidney ensured that he received one—after the police located him in synagogue, attending Shabbat morning services. Date: 6/15/2012


Hadassah Team Develops New Model Which May Save Women Unnecessary Interventions
A study team led by Dr. Carolyn F. Weiniger, an obstetrical anesthesiologist at the Hadassah University Medical Center, has developed a new model for identifying placenta accreta, the abnormal implantation of the placenta into the uterine wall.  Date: 6/15/2012


Hadassah’s Trauma Specialists Publish in Prestigious World Surgery Journal
In an article recently published in the World Journal of Surgery, Hadassah University Medical Center trauma specialists shared their finding: introducing an intensified, high-level supervision approach to trauma care decreases the percent of fatalities. Date: 6/15/2012


Hadassah-Belfast Collaboration Continues to Benefit Patients
A long-standing collaboration between the Hadassah University Medical Center and the Belfast (Ireland) City Hospital Trust Cardiac Anesthesia Department, which began with guest lectures in Israel and Ireland, has led to a joint research project using a ventilator invented in Israel. Date: 6/15/2012


International Team Including Hadassah Traces Hepatitis B Virus to 16th Century Korean Mummy
The discovery of a mummified Korean child with relatively preserved organs enabled an Israeli-South Korean scientific team to conduct genetic analysis which revealed a hepatitis B virus that is common in Southeast Asia. The research team is comprised of scientists from the Hadassah University Medical Center’s Liver Unit; the Hebrew University’s Faculty of Medicine, Koret School of Veterinary Medicine, and the Robert H. Smith Faculty of Agriculture, Food and Environment; and Dankook University and Seoul National University in South Korea. Date: 6/15/2012


Israeli Ministry of Health Announces It Will Pay for Advanced Genetic Testing
The Israeli Ministry of Health has announced that genetic chip testing--the most advanced method to identify chromosomal abnormalities in the amniotic fluid of pregnant women--will be included in the health services covered by the State.  Date: 6/15/2012


Mass Casualty Drill Simulates Reality at Hadassah University Medical Center
A mass casualty drill at Hadassah Hospital-Ein Kerem in early June began with “wounded” victims being brought by ambulance to Hadassah’s Trauma Unit. Date: 6/15/2012


Ukrainian Little Boy’s Life Saved with Bone Marrow Transplant at Hadassah
When four-and-a-half-year-old Zrichko Vladislav was diagnosed with osteopetrosis--a condition where the bones become overly dense and cause damage to nerves and tissues--his feet had already started to bend and he could hardly walk. A bone marrow transplant at the Hadassah University Medical Center saved his life.  Date: 6/15/2012


Hadassah Physician Receives Hebrew University Award for Research on New Type 1 Diabetes Treatment
For her research on a new treatment for Type 1 diabetes, a Hadassah University Medical Center physician has received the Kaye Innovation Award from the Hebrew University. The treatment is now undergoing commercial development. Date: 6/14/2012


With Pride, We Announce the New Director of Hadassah Mt. Scopus

On June 1, Dr. Osnat Levtzion-Korach M.D, M.H.A., will assume the position of Director of the Hadassah University Hospital-Mt. Scopus, succeeding Prof. Zvi Stern, who completed eleven years as Director ofthe hospital. Prof. Stern was recently appointed President of the Jerusalem Academic College of Engineering. 

Date: 5/29/2012


Hadassah Lab Discovery: Special Compound Dramatically Shrinks Lung Tumors
Hadassah University Medical Center researchers have discovered that a special compound called BKT140 shrank lung cell tumors by about 50 percent in cell samples and laboratory mice. When BKT140 was combined with radiation therapy and chemotherapy, cancer cell growth decreased by about 90 percent in lab samples! Date: 5/24/2012


Australian Intensive Care Specialist Chooses to Move to Israel and Join Hadassah Medical Staff
Dr. Peter Vernon Van Heerden, an Australian intensive care specialist with Sir Charles Gairdner Hospital, Perth, and a professor at the University of Western Australia, will shortly be moving to Israel and joining the medical staff of the Hadassah University Medical Center. Date: 5/15/2012


Showing 241 to 260 of 352      First | Prev | 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 | Next | Last


More hMedicine Stories




Hadasit, Hadassah’s Technology Transfer Arm, Reviews 2012’s Accomplishments

When the Hadassah University Medical Center’s physicians suggest a solution to a medical problem which can lead to the development of a new medicine or product, Hadasit, Hadassah’s technology transfer arm, explores its feasibility and supports the promotion of those viable ideas with innovation potential. Although 2012 has been “a year full of challenges for the life science industry,” says Einat Zisman, Hadasit’s Chief Executive Officer, Hadasit still signed 125 agreements for clinical trials, all to be done at Hadassah. In addition, Hadasit signed 15 agreements for cooperation and commercialization of technologies that were developed at Hadassah. Click here to read the latest Newsletter from Hadasit >>

    |  Who We Are  |  What We Do  |  Where We Do It  |  Read About It  |  Join Now  |  Donate  |
  |  Login  |  Contact Us  |  Careers  |  Terms & Conditions  |  
Copyright ©2014 Hadassah is a registered trademark of Hadassah, the Women's Zionist Organization of America